Table 4.
Levels of anxiety and sources of support
| Item | Overall | High risk | Low risk |
|---|---|---|---|
| FTS Plus provided sense of relief and decreased anxiety, median (IQR) | 9.5 (7–10) | 8 (6–10) | 10 (8–10) |
| FTS Plus provided sense of relief and decreased anxiety, n (%) 7/10 | 248 (83.8) | 31 (70.5) | 217 (86.1) |
| Satisfaction with support to overcome worry/anxiety, median (IQR) | 10 (8–10) | 9 (7–10) | 10 (8–10) |
| Satisfaction with support to overcome worry/anxiety, n (%) 7/10 | 263 (87.9) | 38 (84.4) | 225 (88.6) |
| Best source of support following FTS Plus, n (%) | |||
| Support from healthcare provider | 83 (27.6) | 15 (33.3) | 68 (26.6) |
| Support from ultrasound clinic team | 40 (13.3) | 1 (2.2) | 39 (15.2) |
| Ultrasound appointment for health of fetus | 149 (49.5) | 24 (53.3) | 125 (48.8) |
| The resources online | 15 (5) | 2 (4.4) | 13 (5.1) |
| Other | 14 (4.7) | 3 (6.7) | 11 (4.3) |
FTS, first-trimester screening; IQR, interquartile range.
Silang. First-trimester preeclampsia screening and prevention. Am J Obstet Gynecol Glob Rep 2023.